RxSight
RXST
RXST
49 hedge funds and large institutions have $110M invested in RxSight in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% more capital invested
Capital invested by funds: $108M → $110M (+$1.43M)
Holders
49
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$2.91M | |
2 | +$2.48M | |
3 | +$1.91M | |
4 |
BM
Bridger Management
New York
|
+$1.87M |
5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.62M |
Top Sellers
1 | -$6.12M | |
2 | -$351K | |
3 | -$251K | |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$217K |
5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$211K |